Furthermore, who is the leader in CRISPR technology?
14, 2021, 4:05 p.m. In 2020, American biochemist Jennifer Doudna and French microbiologist Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for their discovery of the CRISPR gene-editing technology.Sep 14, 2021
Subsequently, question is, who invested in Crispr Therapeutics? Top 10 Owners of CRISPR Therapeutics AG
| Stockholder | Stake | Shares bought / sold |
|---|---|---|
| ARK Investment Management LLC | 10.03% | -131,769 |
| Capital Research & Management Co. | 5.60% | -325,919 |
| Nikko Asset Management Americas, | 4.44% | -276,409 |
| T. Rowe Price Associates, Inc. (I | 1.56% | -109,056 |
Thereof, who funds CRISPR?
Funds at Cathie Wood's Ark Investment Management snatched up shares of the biotech company and another gene-editing peer Intellia Therapeutics Inc. ahead of Crispr's results. ARK Investment Management is a top holder in Crispr, Intellia and Editas Medicine Inc., all of which use gene-editing technology known as Crispr.Oct 12, 2021
Why does Bill Gates think gene editing?
Why Bill Gates thinks gene editing and artificial intelligence could save the world. “We have an opportunity with the advance of tools like artificial intelligence and gene-based editing technologies to build this new generation of health solutions so that they are available to everyone on the planet.Feb 14, 2020